Gardasil is available poster for a university health clinic
According to the American National Cancer Institute, "Widespread vaccination has the potential to reduce cervical cancer deaths around the world by as much as two-thirds, if all women were to take tVaccination and public health

he vaccine and if protection turns out to be long-term. In addition, the vaccines can reduce the need for medical care, biopsies, and invasive procedures associated with the follow-up from abnormal Pap tests, thus helping to reduce health care costs and anxieties related to abnormal Pap tests and follow-up procedures.
Current preventive vaccines protect against the two HPV types (16 and 18) that cause about 70% of cervical cancers worldwide.Because of the distribution of HPV types associated with cervical cancer, the vaccines are likely to be most effective in Asia, Europe, and North America.Vaccines that protect against more of the types common in cancers would prevent more cancers, and be less subject to regional variation.
Only 41% of women with cervical cancer in the developing world are able to access medical treatment for their illness.Therefore, prevention of HPV by vaccination may be a more effective way of lowering the disease burden in developing countries than cervical screening.[citation needed] However, individuals in many resource-limited nations, Kenya for example, are unable to afford the vaccine.